Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychotherapy01:28

Psychotherapy

684
Psychotherapy is a versatile, nonmedical approach aimed at helping individuals address emotional, behavioral, and interpersonal issues to enhance their overall well-being. It can involve one-on-one sessions, couples counseling, or small group discussions with a therapist. The therapeutic process includes various techniques such as open discussion, interpretation of thoughts and behaviors, active listening, positive reinforcement, and role modeling. Psychotherapy aims to support individuals in...
684
Behavior Therapy01:22

Behavior Therapy

1.0K
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
1.0K
Modeling in Therapy01:26

Modeling in Therapy

753
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
753
Elements Crucial for Effective Psychotherapy01:25

Elements Crucial for Effective Psychotherapy

439
Research has highlighted several critical factors that influence the effectiveness of psychotherapy, such as the therapeutic alliance, the therapist, and the client.
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
439
Drug Therapy01:28

Drug Therapy

418
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
418
Humanistic Therapy01:24

Humanistic Therapy

526
Humanistic therapies emphasize personal growth, self-understanding, and the fulfillment of human potential. Rooted in the belief that individuals inherently strive toward self-actualization, these approaches encourage clients to explore their feelings and experiences in a supportive, nonjudgmental environment. Humanistic therapies differ from psychodynamic approaches by focusing on conscious experiences, present circumstances, and the potential for self-improvement rather than past conflicts...
526

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunogenic implications of translational readthrough modulate the association of F8 nonsense mutations with inhibitors in Hemophilia A.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Italian Patients Journey for Gene Therapy in Haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.

The New England journal of medicine·2026
Same author

United Global Advocacy Drives Updates to World Health Organization Essential Medicines List.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

Building a gene editing lexicon: a model for rare and inherited disorders.

Gene therapy·2026
Same author

Balancing the benefits and risks of rebalancing coagulation in haemophilia.

The Lancet. Haematology·2026

Related Experiment Video

Updated: Apr 17, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

30.0K

Expanding the Toolbox With Non-Factor Therapies.

Maria Elisa Mancuso1,2

  • 1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Haemophilia : the Official Journal of the World Federation of Hemophilia
|April 16, 2026
PubMed
Summary

Prophylaxis prevents bleeds in people with haemophilia (PwH). New therapies offer improved protection, flexibility, and easier administration, addressing limitations of older treatments.

Keywords:
bispecific monoclonal antibodieshaemophiliamimeticsnon‐factor therapiesprophylaxisrebalancing agents

More Related Videos

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

6.6K
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.3K

Related Experiment Videos

Last Updated: Apr 17, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

30.0K
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

6.6K
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.3K

Area of Science:

  • Hematology
  • Pharmacology
  • Internal Medicine

Background:

  • Prophylaxis is standard care for people with haemophilia (PwH), preventing bleeds.
  • Traditional prophylaxis requires frequent intravenous infusions, posing adherence challenges.
  • Limitations include rapid drug clearance and impact on efficacy.

Purpose of the Study:

  • To review advancements in haemophilia prophylaxis.
  • To discuss the evolution from standard half-life to extended half-life and non-factor therapies.
  • To highlight benefits and limitations of new prophylactic treatments.

Main Methods:

  • Review of current literature on haemophilia prophylaxis.
  • Analysis of standard half-life, extended half-life, and non-factor therapies.
  • Discussion of clinical implications and patient outcomes.

Main Results:

  • Extended half-life products offer greater flexibility and fewer infusions.
  • Emicizumab provides subcutaneous prophylaxis for haemophilia A with inhibitors, but breakthrough bleeds can occur.
  • Emerging non-factor therapies promise expanded prophylactic options for various haemophilia types.

Conclusions:

  • Therapeutic options for haemophilia prophylaxis have significantly evolved.
  • Newer agents improve adherence, reduce infusion frequency, and offer new administration routes.
  • Continued innovation aims to provide better protection and personalized care for all PwH.